Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Sevoflurane Market Research Report 2025

Global Sevoflurane Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 84 Pages

Report ld: 3470070

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Sevoflurane Market Size(US$)

CAGR 2025-2031

3.6%

Market Size,2031

USD 1,527

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,234 million

Market Forecast in 2031(Value)

US$ 1,527 million

CAGR

3.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Sevoflurane was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 1527 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.

The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.

One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Sevoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane.

The Sevoflurane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sevoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sevoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Hengrui

Baxter

Maruishi

AbbVie

Piramal

Viatris

PT Novell Pharmaceutical

Lunan Pharma

Segment by Type

Generic Drug

Original Drug

Segment by Application

Hospital

Clinics

Other

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Sevoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Sevoflurane Market Overview

1.1 Product Definition

1.2 Sevoflurane by Type

1.2.1 Global Sevoflurane Market Value Comparison by Type (2024 VS 2031)

1.2.2 Generic Drug

1.2.3 Original Drug

1.3 Sevoflurane by Application

1.3.1 Global Sevoflurane Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Other

1.4 Global Sevoflurane Market Size Estimates and Forecasts

1.4.1 Global Sevoflurane Revenue 2020-2031

1.4.2 Global Sevoflurane Sales 2020-2031

1.4.3 Global Sevoflurane Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Sevoflurane Market Competition by Manufacturers

2.1 Global Sevoflurane Sales Market Share by Manufacturers (2020-2025)

2.2 Global Sevoflurane Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Sevoflurane Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Sevoflurane, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Sevoflurane, Product Type & Application

2.7 Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry

2.8 Global Sevoflurane Market Competitive Situation and Trends

2.8.1 Global Sevoflurane Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Sevoflurane Players Market Share by Revenue

2.8.3 Global Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sevoflurane Market Scenario by Region

3.1 Global Sevoflurane Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Sevoflurane Sales by Region: 2020-2031

3.2.1 Global Sevoflurane Sales by Region: 2020-2025

3.2.2 Global Sevoflurane Sales by Region: 2026-2031

3.3 Global Sevoflurane Revenue by Region: 2020-2031

3.3.1 Global Sevoflurane Revenue by Region: 2020-2025

3.3.2 Global Sevoflurane Revenue by Region: 2026-2031

3.4 North America Sevoflurane Market Facts & Figures by Country

3.4.1 North America Sevoflurane Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Sevoflurane Sales by Country (2020-2031)

3.4.3 North America Sevoflurane Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Sevoflurane Market Facts & Figures by Country

3.5.1 Europe Sevoflurane Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Sevoflurane Sales by Country (2020-2031)

3.5.3 Europe Sevoflurane Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sevoflurane Market Facts & Figures by Region

3.6.1 Asia Pacific Sevoflurane Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Sevoflurane Sales by Region (2020-2031)

3.6.3 Asia Pacific Sevoflurane Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Sevoflurane Market Facts & Figures by Country

3.7.1 Latin America Sevoflurane Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Sevoflurane Sales by Country (2020-2031)

3.7.3 Latin America Sevoflurane Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sevoflurane Market Facts & Figures by Country

3.8.1 Middle East and Africa Sevoflurane Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Sevoflurane Sales by Country (2020-2031)

3.8.3 Middle East and Africa Sevoflurane Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Sevoflurane Sales by Type (2020-2031)

4.1.1 Global Sevoflurane Sales by Type (2020-2025)

4.1.2 Global Sevoflurane Sales by Type (2026-2031)

4.1.3 Global Sevoflurane Sales Market Share by Type (2020-2031)

4.2 Global Sevoflurane Revenue by Type (2020-2031)

4.2.1 Global Sevoflurane Revenue by Type (2020-2025)

4.2.2 Global Sevoflurane Revenue by Type (2026-2031)

4.2.3 Global Sevoflurane Revenue Market Share by Type (2020-2031)

4.3 Global Sevoflurane Price by Type (2020-2031)

5 Segment by Application

5.1 Global Sevoflurane Sales by Application (2020-2031)

5.1.1 Global Sevoflurane Sales by Application (2020-2025)

5.1.2 Global Sevoflurane Sales by Application (2026-2031)

5.1.3 Global Sevoflurane Sales Market Share by Application (2020-2031)

5.2 Global Sevoflurane Revenue by Application (2020-2031)

5.2.1 Global Sevoflurane Revenue by Application (2020-2025)

5.2.2 Global Sevoflurane Revenue by Application (2026-2031)

5.2.3 Global Sevoflurane Revenue Market Share by Application (2020-2031)

5.3 Global Sevoflurane Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Hengrui

6.1.1 Hengrui Company Information

6.1.2 Hengrui Description and Business Overview

6.1.3 Hengrui Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Hengrui Sevoflurane Product Portfolio

6.1.5 Hengrui Recent Developments/Updates

6.2 Baxter

6.2.1 Baxter Company Information

6.2.2 Baxter Description and Business Overview

6.2.3 Baxter Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Baxter Sevoflurane Product Portfolio

6.2.5 Baxter Recent Developments/Updates

6.3 Maruishi

6.3.1 Maruishi Company Information

6.3.2 Maruishi Description and Business Overview

6.3.3 Maruishi Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Maruishi Sevoflurane Product Portfolio

6.3.5 Maruishi Recent Developments/Updates

6.4 AbbVie

6.4.1 AbbVie Company Information

6.4.2 AbbVie Description and Business Overview

6.4.3 AbbVie Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.4.4 AbbVie Sevoflurane Product Portfolio

6.4.5 AbbVie Recent Developments/Updates

6.5 Piramal

6.5.1 Piramal Company Information

6.5.2 Piramal Description and Business Overview

6.5.3 Piramal Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Piramal Sevoflurane Product Portfolio

6.5.5 Piramal Recent Developments/Updates

6.6 Viatris

6.6.1 Viatris Company Information

6.6.2 Viatris Description and Business Overview

6.6.3 Viatris Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Viatris Sevoflurane Product Portfolio

6.6.5 Viatris Recent Developments/Updates

6.7 PT Novell Pharmaceutical

6.7.1 PT Novell Pharmaceutical Company Information

6.7.2 PT Novell Pharmaceutical Description and Business Overview

6.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.7.4 PT Novell Pharmaceutical Sevoflurane Product Portfolio

6.7.5 PT Novell Pharmaceutical Recent Developments/Updates

6.8 Lunan Pharma

6.8.1 Lunan Pharma Company Information

6.8.2 Lunan Pharma Description and Business Overview

6.8.3 Lunan Pharma Sevoflurane Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Lunan Pharma Sevoflurane Product Portfolio

6.8.5 Lunan Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sevoflurane Industry Chain Analysis

7.2 Sevoflurane Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sevoflurane Production Mode & Process Analysis

7.4 Sevoflurane Sales and Marketing

7.4.1 Sevoflurane Sales Channels

7.4.2 Sevoflurane Distributors

7.5 Sevoflurane Customer Analysis

8 Sevoflurane Market Dynamics

8.1 Sevoflurane Industry Trends

8.2 Sevoflurane Market Drivers

8.3 Sevoflurane Market Challenges

8.4 Sevoflurane Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Sevoflurane Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Sevoflurane Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Sevoflurane Market Competitive Situation by Manufacturers in 2024

Table 4. Global Sevoflurane Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Sevoflurane Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Sevoflurane Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Sevoflurane Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Sevoflurane Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Sevoflurane, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Sevoflurane, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Sevoflurane, Product Type & Application

Table 12. Global Key Manufacturers of Sevoflurane, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sevoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sevoflurane Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Sevoflurane Sales by Region (2020-2025) & (K Units)

Table 18. Global Sevoflurane Sales Market Share by Region (2020-2025)

Table 19. Global Sevoflurane Sales by Region (2026-2031) & (K Units)

Table 20. Global Sevoflurane Sales Market Share by Region (2026-2031)

Table 21. Global Sevoflurane Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Sevoflurane Revenue Market Share by Region (2020-2025)

Table 23. Global Sevoflurane Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Sevoflurane Revenue Market Share by Region (2026-2031)

Table 25. North America Sevoflurane Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Sevoflurane Sales by Country (2020-2025) & (K Units)

Table 27. North America Sevoflurane Sales by Country (2026-2031) & (K Units)

Table 28. North America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Sevoflurane Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Sevoflurane Sales by Country (2020-2025) & (K Units)

Table 32. Europe Sevoflurane Sales by Country (2026-2031) & (K Units)

Table 33. Europe Sevoflurane Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Sevoflurane Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Sevoflurane Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Sevoflurane Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Sevoflurane Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Sevoflurane Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Sevoflurane Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sevoflurane Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Sevoflurane Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Sevoflurane Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Sevoflurane Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Sevoflurane Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Sevoflurane Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Sevoflurane Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Sevoflurane Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Sevoflurane Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Sevoflurane Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Sevoflurane Sales (K Units) by Type (2020-2025)

Table 51. Global Sevoflurane Sales (K Units) by Type (2026-2031)

Table 52. Global Sevoflurane Sales Market Share by Type (2020-2025)

Table 53. Global Sevoflurane Sales Market Share by Type (2026-2031)

Table 54. Global Sevoflurane Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Sevoflurane Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Sevoflurane Revenue Market Share by Type (2020-2025)

Table 57. Global Sevoflurane Revenue Market Share by Type (2026-2031)

Table 58. Global Sevoflurane Price (US$/Unit) by Type (2020-2025)

Table 59. Global Sevoflurane Price (US$/Unit) by Type (2026-2031)

Table 60. Global Sevoflurane Sales (K Units) by Application (2020-2025)

Table 61. Global Sevoflurane Sales (K Units) by Application (2026-2031)

Table 62. Global Sevoflurane Sales Market Share by Application (2020-2025)

Table 63. Global Sevoflurane Sales Market Share by Application (2026-2031)

Table 64. Global Sevoflurane Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Sevoflurane Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Sevoflurane Revenue Market Share by Application (2020-2025)

Table 67. Global Sevoflurane Revenue Market Share by Application (2026-2031)

Table 68. Global Sevoflurane Price (US$/Unit) by Application (2020-2025)

Table 69. Global Sevoflurane Price (US$/Unit) by Application (2026-2031)

Table 70. Hengrui Company Information

Table 71. Hengrui Description and Business Overview

Table 72. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Hengrui Sevoflurane Product

Table 74. Hengrui Recent Developments/Updates

Table 75. Baxter Company Information

Table 76. Baxter Description and Business Overview

Table 77. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Baxter Sevoflurane Product

Table 79. Baxter Recent Developments/Updates

Table 80. Maruishi Company Information

Table 81. Maruishi Description and Business Overview

Table 82. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Maruishi Sevoflurane Product

Table 84. Maruishi Recent Developments/Updates

Table 85. AbbVie Company Information

Table 86. AbbVie Description and Business Overview

Table 87. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. AbbVie Sevoflurane Product

Table 89. AbbVie Recent Developments/Updates

Table 90. Piramal Company Information

Table 91. Piramal Description and Business Overview

Table 92. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Piramal Sevoflurane Product

Table 94. Piramal Recent Developments/Updates

Table 95. Viatris Company Information

Table 96. Viatris Description and Business Overview

Table 97. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Viatris Sevoflurane Product

Table 99. Viatris Recent Developments/Updates

Table 100. PT Novell Pharmaceutical Company Information

Table 101. PT Novell Pharmaceutical Description and Business Overview

Table 102. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. PT Novell Pharmaceutical Sevoflurane Product

Table 104. PT Novell Pharmaceutical Recent Developments/Updates

Table 105. Lunan Pharma Company Information

Table 106. Lunan Pharma Description and Business Overview

Table 107. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Lunan Pharma Sevoflurane Product

Table 109. Lunan Pharma Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Sevoflurane Distributors List

Table 113. Sevoflurane Customers List

Table 114. Sevoflurane Market Trends

Table 115. Sevoflurane Market Drivers

Table 116. Sevoflurane Market Challenges

Table 117. Sevoflurane Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sevoflurane

Figure 2. Global Sevoflurane Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sevoflurane Market Share by Type: 2024 & 2031

Figure 4. Generic Drug Product Picture

Figure 5. Original Drug Product Picture

Figure 6. Global Sevoflurane Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Sevoflurane Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinics

Figure 10. Other

Figure 11. Global Sevoflurane Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Sevoflurane Market Size (2020-2031) & (US$ Million)

Figure 13. Global Sevoflurane Sales (2020-2031) & (K Units)

Figure 14. Global Sevoflurane Average Price (US$/Unit) & (2020-2031)

Figure 15. Sevoflurane Report Years Considered

Figure 16. Sevoflurane Sales Share by Manufacturers in 2024

Figure 17. Global Sevoflurane Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Sevoflurane Players: Market Share by Revenue in Sevoflurane in 2024

Figure 19. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Sevoflurane Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Sevoflurane Sales Market Share by Country (2020-2031)

Figure 22. North America Sevoflurane Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Sevoflurane Sales Market Share by Country (2020-2031)

Figure 26. Europe Sevoflurane Revenue Market Share by Country (2020-2031)

Figure 27. Germany Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Sevoflurane Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Sevoflurane Revenue Market Share by Region (2020-2031)

Figure 34. China Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Sevoflurane Sales Market Share by Country (2020-2031)

Figure 45. Latin America Sevoflurane Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Sevoflurane Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Sevoflurane Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Sevoflurane Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Sevoflurane by Type (2020-2031)

Figure 55. Global Revenue Market Share of Sevoflurane by Type (2020-2031)

Figure 56. Global Sevoflurane Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Sevoflurane by Application (2020-2031)

Figure 58. Global Revenue Market Share of Sevoflurane by Application (2020-2031)

Figure 59. Global Sevoflurane Price (US$/Unit) by Application (2020-2031)

Figure 60. Sevoflurane Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Sevoflurane in 2031? zhanKai

The global market size of Sevoflurane in 2031 was 1527 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Sevoflurane market? shouQi

What was the global market size of Sevoflurane in 2025? shouQi

What is the annual compound growth rate of the global Sevoflurane market size from 2025 to 2031? shouQi

Related Reports

Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sevoflurane market size was US$ 1234 million in 2025 and is forecast to reach a readjusted size of US$ 1577 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Sevoflurane Market Research Report 2026
The global Sevoflurane market was valued at US$ 1234 million in 2025 and is anticipated to reach US$ 1577 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 113
USD 2900.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sevoflurane was estimated to be worth US$ 1234 million in 2025 and is projected to reach US$ 1577 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 94
USD 3950.00
(Single User License)
Global Sevoflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sevoflurane market is projected to grow from US$ 1195 million in 2024 to US$ 1527 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 134
USD 4900.00
(Single User License)
Global Sevoflurane Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Sevoflurane was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sevoflurane market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sevoflurane was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 93
USD 3950.00
(Single User License)
Global and China Sevoflurane Market Report & Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 105
USD 4350.00
(Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 107
USD 3950.00
(Single User License)
Global Sevoflurane Market Insights, Forecast to 2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published Date: 2024-09-11
Pages: 135
USD 4900.00
(Single User License)

Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sevoflurane market size was US$ 1234 million in 2025 and is forecast to reach a readjusted size of US$ 1577 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)
Global Sevoflurane Market Research Report 2026
The global Sevoflurane market was valued at US$ 1234 million in 2025 and is anticipated to reach US$ 1577 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 113
USD 2900.00 (Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sevoflurane was estimated to be worth US$ 1234 million in 2025 and is projected to reach US$ 1577 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 94
USD 3950.00 (Single User License)
Global Sevoflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sevoflurane market is projected to grow from US$ 1195 million in 2024 to US$ 1527 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 134
USD 4900.00 (Single User License)
Global Sevoflurane Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Sevoflurane was estimated to be worth US$ 1195 million and is forecast to reach approximately US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
USD 5900.00 (Single User License)
Global Sevoflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sevoflurane market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
USD 4250.00 (Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sevoflurane was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 93
USD 3950.00 (Single User License)
Global and China Sevoflurane Market Report & Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 105
USD 4350.00 (Single User License)
Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 107
USD 3950.00 (Single User License)
Global Sevoflurane Market Insights, Forecast to 2030
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
Published: 2024-09-11
Pages: 135
USD 4900.00 (Single User License)